1 / 52

Drug-Eluting Stents in Challenging Lesions: Randomized Trials and Registries

Drug-Eluting Stents in Challenging Lesions: Randomized Trials and Registries. Outline. Definition of challenging lesion Aorto-ostial lesions Bifurcation lesions Unprotected left main Thrombotic lesions Total occlusions Safenous vein grafts Long lesions and small vessels Diabetics

zelig
Download Presentation

Drug-Eluting Stents in Challenging Lesions: Randomized Trials and Registries

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug-Eluting Stents in Challenging Lesions: Randomized Trials and Registries

  2. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  3. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  4. Definition of challenging lesion Any lesion with features associated with a higher risk of procedural failure or peri-procedural adverse events

  5. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  6. Iakovou et al, JACC 2004

  7. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  8. Steigen et al, Circulation 2006

  9. Di Mario et al, CCI 2006

  10. Di Mario et al, CCI 2006

  11. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  12. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  13. Pasceri et al, AHJ 2005

  14. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  15. Suttorp et al, Circ 2006

  16. Werner et al, CCI 2005

  17. Werner et al, CCI 2005

  18. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  19. Vermeersch et al, JACC 2007

  20. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  21. Ardissino et al, JAMA 2004

  22. Stone et al, JAMA 2005

  23. Dawkins et al, Circulation 2005

  24. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  25. Spaulding et al, NEJM 2007

  26. TAXUS diabetics meta-analysis (N=715) BMS PES Baim, FDA Panel 2006

  27. Outline • Definition of challenging lesion • Aorto-ostial lesions • Bifurcation lesions • Unprotected left main • Thrombotic lesions • Total occlusions • Safenous vein grafts • Long lesions and small vessels • Diabetics • TRUE Study

  28. TRUETaxus™ Multicenter Registry European (Taxus in Real-life Usage Evaluation)

  29. 60% 50% 40% 30% 20% 10% 0% 14 16 18 20 22 8 10 12 The complexity of lesions in TRUE 70% Complex Lesions Lesion Complexity (% C Type) Long Lesions ENDEAVOR I TAXUS VI DELIVER II TAXUS IV FUTURE I C-SIRIUS E-SIRIUS TRUE FUTURE II DELIVER I TAXUS II RAVEL SIRIUS ACTION TAXUS I ASPECT ELUTES Mean lesion length (mm)

  30. Patient distribution (n=1065) by intentional treatment Unprotected Left Main n=115 (11%) Diabetes n=322 (30%) Long lesions n=289 (27%) Bifurcations Trifurcations n=229 (22%) Small vessels n=430 (40%) CTO n=191 (18%)

  31. Overall 7-month follow-up (N=1065) Incidence %

  32. Overall 12-month follow-up (N=1065) Incidence %

  33. Overall ARC-probable stent thrombosis (n=1065) Incidence %

  34. Kaplan-Meier curve for event-free survival 1,0 ,9 ,8 Survival free from MACE ,7 ,6 ,5 0 4 8 12 2 6 10 Time (months)

  35. Kaplan-Meier curve for stent thrombosis-free survival 1,0 ,9 ,8 Survival free from thrombosis-related events ,7 ,6 ,5 0 4 8 12 2 6 10 Time (months)

  36. Unprotected left main 7-month follow-up (N=115) Incidence %

  37. Chronic total occlusions 7-month follow-up (N=191) Incidence % N=24 N=18 N=25 N=4 N=2 N=2

  38. Diabetes mellitus 7-month follow-up (N=322) Incidence %

  39. Take home messages

More Related